|
US6773669B1
(en)
|
1995-03-10 |
2004-08-10 |
Maxcyte, Inc. |
Flow electroporation chamber and method
|
|
US6090617A
(en)
|
1996-12-05 |
2000-07-18 |
Entremed, Inc. |
Flow electroporation chamber with electrodes having a crystalline metal nitride coating
|
|
US6534261B1
(en)
|
1999-01-12 |
2003-03-18 |
Sangamo Biosciences, Inc. |
Regulation of endogenous gene expression in cells using zinc finger proteins
|
|
AU5574801A
(en)
|
2000-04-28 |
2001-11-12 |
Sangamo Biosciences Inc |
Methods for binding an exogenous molecule to cellular chromatin
|
|
US7029916B2
(en)
|
2001-02-21 |
2006-04-18 |
Maxcyte, Inc. |
Apparatus and method for flow electroporation of biological samples
|
|
ES2230502T3
(es)
|
2001-04-23 |
2005-05-01 |
Amaxa Gmbh |
Disolucion tampon para la electroporacion y procedimiento que incluye el uso de la misma.
|
|
EP1456345B1
(en)
|
2001-08-22 |
2016-07-20 |
Maxcyte, Inc. |
Apparatus and method for electroporation of biological samples
|
|
US20050136040A1
(en)
|
2001-10-11 |
2005-06-23 |
Imperial College Innovations Limited |
Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
|
|
GB0124391D0
(en)
|
2001-10-11 |
2001-11-28 |
Gene Expression Technologies L |
Control of gene expression
|
|
US20030232410A1
(en)
|
2002-03-21 |
2003-12-18 |
Monika Liljedahl |
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
|
|
ITMI20030821A1
(it)
|
2003-04-18 |
2004-10-19 |
Internat Ct For Genetic En Gineering And |
Polipeptidi chimerici e loro uso.
|
|
EP1631676A4
(en)
|
2003-06-10 |
2006-12-20 |
Toolgen Inc |
TRANSDUCIBLE DNA BINDING PROTEINS
|
|
US8133733B2
(en)
|
2003-10-24 |
2012-03-13 |
Gencia Corporation |
Nonviral vectors for delivering polynucleotides to target tissues
|
|
ATE437940T1
(de)
|
2004-03-15 |
2009-08-15 |
Lonza Cologne Ag |
Behältnis und vorrichtung zur erzeugung von elektrischen feldern in einzelnen reaktionsräumen
|
|
DK1766057T3
(en)
|
2004-05-12 |
2015-03-02 |
Maxcyte Inc |
Methods and devices related to a regulated flowelektroporationskammer
|
|
WO2006001614A1
(en)
|
2004-06-12 |
2006-01-05 |
Digital Bio Technology Co., Ltd. |
Electroporator having an elongated hollow member
|
|
WO2005123962A2
(en)
|
2004-06-14 |
2005-12-29 |
The University Of Texas At Austin |
Gene targeting in eukaryotic cells by group ii intron ribonucleoprotein particles
|
|
ES2465467T3
(es)
|
2004-06-14 |
2014-06-05 |
Lonza Cologne Ag |
Procedimiento y disposición de circuito para el tratamiento de material biológico
|
|
EP1817406A2
(en)
|
2004-11-30 |
2007-08-15 |
Maxcyte, Inc. |
Computerized electroporation
|
|
US10022457B2
(en)
|
2005-08-05 |
2018-07-17 |
Gholam A. Peyman |
Methods to regulate polarization and enhance function of cells
|
|
EP2325332B1
(en)
|
2005-08-26 |
2012-10-31 |
DuPont Nutrition Biosciences ApS |
Use of CRISPR associated genes (CAS)
|
|
WO2008021207A2
(en)
|
2006-08-11 |
2008-02-21 |
Dow Agrosciences Llc |
Zinc finger nuclease-mediated homologous recombination
|
|
DK2279253T3
(en)
|
2008-04-09 |
2017-02-13 |
Maxcyte Inc |
Construction and application of therapeutic compositions of freshly isolated cells
|
|
DK2310500T3
(en)
|
2008-07-18 |
2015-05-11 |
Maxcyte Inc |
Process for optimizing electroporation
|
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
|
JP2012525146A
(ja)
|
2009-04-28 |
2012-10-22 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
細胞透過のための過剰に荷電されたタンパク質
|
|
WO2011059836A2
(en)
|
2009-10-29 |
2011-05-19 |
Trustees Of Dartmouth College |
T cell receptor-deficient t cell compositions
|
|
US8956828B2
(en)
*
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
|
CA2783351C
(en)
|
2009-12-10 |
2021-09-07 |
Regents Of The University Of Minnesota |
Tal effector-mediated dna modification
|
|
US9567573B2
(en)
|
2010-04-26 |
2017-02-14 |
Sangamo Biosciences, Inc. |
Genome editing of a Rosa locus using nucleases
|
|
US8876458B2
(en)
|
2011-01-25 |
2014-11-04 |
United Technologies Corporation |
Blade outer air seal assembly and support
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
|
US20130236504A1
(en)
|
2012-03-06 |
2013-09-12 |
Medical University Of South Carolina |
Delivery System for Enhancing Drug Efficacy
|
|
FI3597749T3
(fi)
|
2012-05-25 |
2023-10-09 |
Univ California |
Menetelmiä ja koostumuksia rna-ohjattua kohde-dna-modifikaatiota varten ja rna-ohjattua transkription modulaatiota varten
|
|
KR101656236B1
(ko)
|
2012-10-23 |
2016-09-12 |
주식회사 툴젠 |
표적 DNA에 특이적인 가이드 RNA 및 Cas 단백질을 암호화하는 핵산 또는 Cas 단백질을 포함하는, 표적 DNA를 절단하기 위한 조성물 및 이의 용도
|
|
PT3363902T
(pt)
|
2012-12-06 |
2019-12-19 |
Sigma Aldrich Co Llc |
Modificação e regulação de genoma baseadas em crispr
|
|
EP2931899A1
(en)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
|
EP4234696A3
(en)
|
2012-12-12 |
2023-09-06 |
The Broad Institute Inc. |
Crispr-cas component systems, methods and compositions for sequence manipulation
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
EP4282970A3
(en)
|
2012-12-17 |
2024-01-17 |
President and Fellows of Harvard College |
Rna-guided human genome engineering
|
|
KR102874079B1
(ko)
|
2013-03-15 |
2025-10-22 |
더 제너럴 하스피탈 코포레이션 |
Rna-안내 게놈 편집을 위해 특이성을 증가시키기 위한 절단된 안내 rna(tru-grnas)의 이용
|
|
SG11201506991VA
(en)
*
|
2013-03-15 |
2015-10-29 |
Adaptive Biotechnologies Corp |
Uniquely tagged rearranged adaptive immune receptor genes in a complex gene set
|
|
EP2975942B1
(en)
|
2013-03-21 |
2018-08-08 |
Sangamo Therapeutics, Inc. |
Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases
|
|
WO2014161821A1
(en)
|
2013-04-02 |
2014-10-09 |
Bayer Cropscience Nv |
Targeted genome engineering in eukaryotes
|
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
|
DK3004337T3
(da)
*
|
2013-05-29 |
2017-11-13 |
Cellectis |
Fremgangsmåde til konstruktion af T-celler til immunoterapi ved brug af RNA-guidet Cas nuklease-system
|
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
|
US10822606B2
(en)
|
2013-09-27 |
2020-11-03 |
The Regents Of The University Of California |
Optimized small guide RNAs and methods of use
|
|
US9957526B2
(en)
|
2013-10-17 |
2018-05-01 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
CA2930590C
(en)
|
2013-11-15 |
2021-02-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Engineering neural stem cells using homologous recombination
|
|
EP3080271B1
(en)
|
2013-12-12 |
2020-02-12 |
The Broad Institute, Inc. |
Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
|
|
BR112016013201B1
(pt)
|
2013-12-12 |
2023-01-31 |
The Broad Institute, Inc. |
Uso de uma composição compreendendo um sistema crispr-cas no tratamento de uma doença genética ocular
|
|
EP3079726B1
(en)
|
2013-12-12 |
2018-12-05 |
The Broad Institute, Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
|
|
EP3080256B1
(en)
|
2013-12-13 |
2018-06-13 |
Cellectis |
Cas9 nuclease platform for microalgae genome engineering
|
|
WO2015117021A1
(en)
|
2014-01-31 |
2015-08-06 |
Factor Bioscience Inc. |
Methods and products for nucleic acid production and delivery
|
|
WO2015115903A1
(en)
|
2014-02-03 |
2015-08-06 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Site-specific dna break-induced genome editing using engineered nucleases
|
|
WO2015161276A2
(en)
|
2014-04-18 |
2015-10-22 |
Editas Medicine, Inc. |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
US10570418B2
(en)
|
2014-09-02 |
2020-02-25 |
The Regents Of The University Of California |
Methods and compositions for RNA-directed target DNA modification
|
|
KR20170083534A
(ko)
*
|
2014-09-19 |
2017-07-18 |
리제너론 파마슈티칼스 인코포레이티드 |
키메라 항원 수용체
|
|
WO2016049251A1
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling mutations in leukocytes
|
|
EP3204513A2
(en)
|
2014-10-09 |
2017-08-16 |
Life Technologies Corporation |
Crispr oligonucleotides and gene editing
|
|
EP4427809A3
(en)
|
2014-10-31 |
2024-12-04 |
The Trustees of The University of Pennsylvania |
Altering gene expression in car-t cells and uses thereof
|
|
WO2016097751A1
(en)
|
2014-12-18 |
2016-06-23 |
The University Of Bath |
Method of cas9 mediated genome engineering
|
|
CN114642735A
(zh)
|
2015-01-21 |
2022-06-21 |
菲泽尔克斯公司 |
用于将治疗剂和诊断剂递送到细胞中的方法、组合物和系统
|
|
ES2880473T5
(es)
|
2015-01-30 |
2024-05-09 |
Univ California |
Suministro de proteínas en células hematopoyéticas primarias
|
|
US12129471B2
(en)
|
2015-02-23 |
2024-10-29 |
Vertex Pharmaceuticals Incorporated |
Materials and methods for treatment of human genetic diseases including hemoglobinopathies
|
|
US20180298340A1
(en)
|
2015-04-24 |
2018-10-18 |
The Regents Of The University Of California |
Systems for detecting, monitoring or treating diseases or conditions using engineered cells and methods for making and using them
|
|
WO2016196388A1
(en)
|
2015-05-29 |
2016-12-08 |
Juno Therapeutics, Inc. |
Composition and methods for regulating inhibitory interactions in genetically engineered cells
|
|
WO2016205680A1
(en)
|
2015-06-17 |
2016-12-22 |
The Uab Research Foundation |
Crispr/cas9 complex for introducing a functional polypeptide into cells of blood cell lineage
|
|
WO2016205703A1
(en)
|
2015-06-17 |
2016-12-22 |
The Uab Research Foundation |
Crispr/cas9 complex for genomic editing
|
|
US20170000743A1
(en)
|
2015-07-02 |
2017-01-05 |
Vindico NanoBio Technology Inc. |
Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles
|
|
WO2017011519A1
(en)
|
2015-07-13 |
2017-01-19 |
Sangamo Biosciences, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
US9512446B1
(en)
|
2015-08-28 |
2016-12-06 |
The General Hospital Corporation |
Engineered CRISPR-Cas9 nucleases
|
|
CA2996913A1
(en)
|
2015-09-01 |
2017-03-09 |
The Hospital For Sick Children |
Method and compositions for removing duplicated copy number variations (cnvs) for genetic disorders and related uses
|
|
WO2017044661A1
(en)
*
|
2015-09-09 |
2017-03-16 |
Immune Design Corp. |
Ny-eso-1 specific tcrs and methods of use thereof
|
|
WO2017053729A1
(en)
|
2015-09-25 |
2017-03-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nuclease-mediated genome editing of primary cells and enrichment thereof
|
|
WO2017058751A1
(en)
|
2015-09-28 |
2017-04-06 |
North Carolina State University |
Methods and compositions for sequence specific antimicrobials
|
|
EP4108255A1
(en)
*
|
2015-10-05 |
2022-12-28 |
Precision Biosciences, Inc. |
Genetically-modified cells comprising a modified human t cell receptor alpha constant region gene
|
|
AU2016333886B2
(en)
*
|
2015-10-05 |
2020-10-08 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene
|
|
WO2017070169A1
(en)
|
2015-10-19 |
2017-04-27 |
The Methodist Hospital |
Crispr-cas9 delivery to hard-to-transfect cells via membrane deformation
|
|
US20180312873A1
(en)
|
2015-10-20 |
2018-11-01 |
10X Genomics, Inc. |
Method and systems for high throughput single cell genetic manipulation
|
|
WO2017070429A1
(en)
|
2015-10-22 |
2017-04-27 |
Regents Of The University Of Minnesota |
Methods involving editing polynucleotides that encode t cell receptor
|
|
KR20250141836A
(ko)
|
2015-11-04 |
2025-09-29 |
페이트 세러퓨틱스, 인코포레이티드 |
만능 세포의 유전자 조작
|
|
AU2016359629B2
(en)
|
2015-11-23 |
2023-03-09 |
Ranjan BATRA |
Tracking and manipulating cellular RNA via nuclear delivery of CRISPR/Cas9
|
|
ES2983043T3
(es)
|
2015-12-18 |
2024-10-21 |
Sangamo Therapeutics Inc |
Alteración dirigida del receptor de células T
|
|
US11827899B2
(en)
|
2015-12-30 |
2023-11-28 |
Avectas Limited |
Vector-free delivery of gene editing proteins and compositions to cells and tissues
|
|
AU2017230011A1
(en)
*
|
2016-03-11 |
2018-09-27 |
2Seventy Bio, Inc. |
Genome edited immune effector cells
|
|
CA3020330A1
(en)
|
2016-04-07 |
2017-10-12 |
Bluebird Bio, Inc. |
Chimeric antigen receptor t cell compositions
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
AU2017250295B2
(en)
|
2016-04-14 |
2022-08-25 |
Fred Hutchinson Cancer Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
CA3020923A1
(en)
*
|
2016-04-15 |
2017-10-19 |
Memorial Sloan Kettering Cancer Center |
Transgenic t cell and chimeric antigen receptor t cell compositions and related methods
|
|
US11248216B2
(en)
|
2016-04-25 |
2022-02-15 |
The Regents Of The University Of California |
Methods and compositions for genomic editing
|
|
US11608499B2
(en)
|
2016-04-29 |
2023-03-21 |
Basf Plant Science Company Gmbh |
Methods for modification of target nucleic acids
|
|
US20190136224A1
(en)
|
2016-05-31 |
2019-05-09 |
Massachusetts Institute Of Technology |
Hydrodynamically Controlled Electric Fields for High Throughput Transformation & High Throughput Parallel Transformation Platform
|
|
EP3472338B1
(en)
|
2016-06-20 |
2024-05-22 |
Octapharma AG |
Means and methods for modifying multiple alleles
|
|
WO2018035387A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2018039084A1
(en)
|
2016-08-20 |
2018-03-01 |
The Regents Of The University Of California |
High-throughput system and method for the temporary permeablization of cells
|
|
WO2018068135A1
(en)
|
2016-10-12 |
2018-04-19 |
Feldan Bio Inc. |
Rationally-designed synthetic peptide shuttle agents for delivering polypeptide cargos from an extracellular space to the cytosol and/or nucleus of a target eukaryotic cell, uses thereof, methods and kits relating to same
|
|
WO2018073391A1
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Targeted gene insertion for improved immune cells therapy
|
|
WO2018073393A2
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
|
|
EP3541937A4
(en)
|
2016-11-18 |
2020-06-24 |
Christopher Bradley |
REPAIR OF MASSIVELY MULTIPLEXED HOMOLOGICAL TEMPLATE FOR FULL GENERATION
|
|
JP7317706B2
(ja)
|
2016-12-14 |
2023-07-31 |
リガンダル インコーポレイテッド |
核酸およびタンパク質ペイロード送達のための方法および組成物
|
|
CA3048645A1
(en)
|
2016-12-30 |
2018-07-05 |
The Regents Of The University Of California |
Methods for selection and generation of genome edited t cells
|
|
KR102720855B1
(ko)
|
2017-06-15 |
2024-10-25 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
표적화된 비-바이러스 dna 삽입
|
|
KR102503130B1
(ko)
*
|
2017-10-27 |
2023-02-24 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
내인성 t 세포 수용체의 표적화된 대체
|
|
MX2020004541A
(es)
|
2017-10-30 |
2021-04-12 |
Pact Pharma Inc |
Edicion de genes de celulas primarias.
|